Clinical Trials
3 trialsNCT01946477 2026-05-22
POM MM 014
Celgene
Phase 2 Completed
NCT02136134 2025-08-29
Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
Janssen Research & Development, LLC
Phase 3 Completed
NCT04065308 2019-08-22
Dara_DCEP
Seoul National University Hospital
Phase 2 Unknown